Spire Wealth Management Novo Cure LTD Transaction History

Spire Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$56.44 - $118.81 $733 - $1,544	-13 Reduced 39.39%	20 $1,000
Q4 2022 Feb 03, 2023	BUY	$63.98 - $85.37 $2,111 - $2,817	33 New	33 $2,000
Q1 2022 Apr 18, 2022	SELL	$60.15 - $84.52 $1,624 - $2,282	-27 Reduced 21.26%	100 $8,000
Q4 2021 Jan 14, 2022	BUY	$75.08 - $121.99 $9,535 - $15,492	127 New	127 $10,000
Q3 2021 Oct 22, 2021	SELL	$116.17 - $194.55 $21,723 - $36,380	-187 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$130.4 - $225.58 $391 - $676	3 Added 1.63%	187 $41,000
Q1 2021 May 21, 2021	BUY	$124.11 - $190.17 $22,836 - $34,991	184 New	184 $24,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.